news
MHRA suspends license for Picato over concerns of skin malignancy risk
The marketing license for ingenol mebutate gel (Picato) has been suspended by the MHRA due to studies showing an increased risk of skin malignancies from the drug.
List view / Grid view
MHRA
news
PDA explores the transformation of healthcare at 4th Annual European Meeting
The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting.
news
Three further Losartan batches recalled
The MHRA has recalled three batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid...
article
The impact of Brexit on life sciences
On 30 March 2019 the UK is set to leave the European Union (EU), a process that has become popularly known as Brexit. One little talked-about aspect of this move in the mainstream media is the impact it will have on the British life science community. Researchers and industry leaders…
news
Wickham Labs to Exhibit at Pharmig 2016
3 November 2016 | By Wickham Laboratories Limited
Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th...
news
Wickham Laboratories Announces Renewal of FDA Accreditation
20 October 2016 | By Wickham Laboratories
Wickham Laboratories reports a successful completion of the FDA auditing process with renewal of GMP accreditation....
news
EFPIA releases statement on Brexit
30 June 2016 | By Victoria White, Digital Content Producer
In the statement, EFPIA underscores the importance of ensuring that the patient is at the centre of all subsequent decisions...
news
Gang sentenced for illegal importation and sale of drugs in the UK
14 June 2016 | By Victoria White, Digital Content Producer
The gang imported over 1.2 million unlicensed erectile dysfunction tablets and over 141,000 other illegal medicines including diazepam worth over £3.5 million...
news
MHRA approves bionic vision system clinical trial
31 May 2016 | By Victoria White, Digital Content Producer
Pixium Vision has received approval from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK to initiate a clinical trial for patients who have lost sight due to retinitis pigmentosa (RP) with the IRIS II bionic vision system.
article
UK life sciences are stronger in the EU, says BioIndustry Association
16 March 2016 | By Steve Bates, BioIndustry Association (BIA) Chief Executive
Here, Steve Bates, Chief Executive of the BioIndustry Association (BIA), makes a case for the UK remaining in the EU from the perspective of the life sciences sector...
news
New toolkit informs of the risks of taking valproate during pregnancy
8 February 2016 | By Victoria White
Valproate is associated with a risk of birth defects and developmental disorders in children born to women who take the treatment during pregnancy...
news
MHRA warns of the dangers of buying diet pills online
4 January 2016 | By Victoria White
Since 2005, MHRA officials have found hundreds of examples of medicines claiming to contain herbal ingredients but after analysis were found to be adulterated with pharmaceutical ingredients...
news
MHRA helps make dementia medicine packaging more user-friendly
4 November 2015 | By Victoria White
From June 2016, medicines for the treatment of dementia will include the days of the week clearly on the blister packs...
news
MHRA seizes huge haul of unlicensed medicines
23 October 2015 | By Victoria White
MHRA Enforcement officers seized nearly £1 million worth of unlicensed erectile dysfunction medicines from an address in Slough...
news
MHRA and India regulators agree deal to improve public safety
6 October 2015 | By Victoria White
A Memorandum of Understanding will increase collaboration between the two countries in the area of medicines and medical devices with the aim of further improving public safety...
